Migraine Attack Pain Phase Prediction Study

Launched by FUNDACIÓN DE INVESTIGACIÓN BIOMÉDICA - HOSPITAL UNIVERSITARIO DE LA PRINCESA · Jun 10, 2024

Keywords

ClinConnect Summary

The Migraine Attack Pain Phase Prediction Study is a clinical trial designed to explore how to predict the pain levels during a migraine attack. Researchers will examine early warning signs, known as premonitory symptoms, and will use a special monitoring device that records real-time body measurements to understand how these signs relate to the onset of migraine pain. This study is part of ongoing research at the Hospital de La Princesa in collaboration with universities in Madrid and aims to improve treatment and management of migraines.

To participate in this study, you must be between 15 and 69 years old, have a diagnosis of migraine from a specialist, and experience 10 to 14 migraine days each month. You should also be comfortable using smartphone devices and able to commit to two months of follow-up. Throughout the study, participants will be monitored for their symptoms and provided with guidance on how to track their migraines. It’s important to know that there are specific health conditions that could exclude someone from participating, such as certain heart diseases or having other types of headaches. This trial hopes to provide valuable insights into better predicting and managing migraine attacks.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age between 15 years and 69 years.
• • Diagnosed with migraine by a headache neurologist and according to the criteria proposed by ICHD-3.
• • History of migraine of at least 1 year of evolution.
• • Normal neurological examination.
• • Have given your informed consent.
• • Be able to describe your clinical situation and the characteristics of your headache.
• • Have an average of 10 to 14 migraine days per month in the three months prior to inclusion (high-frequency episodic migraine).
• • User-level management capacity of "smartphone" type electronic devices.
• • Be able to complete two months of study follow-up.
• Exclusion Criteria:
• • Presence of another type of headache, with the exception of headache due to excessive use of analgesic medication.
• • Cognitive deficiency or any other pathology that may prevent or make it difficult for the patient to perform the study correctly.
• • Neurological focus in the examination.
• • Pregnancy or breastfeeding period.
• • Patients with known heart disease or bronchopathy, Sjögren\'s syndrome, diabetes mellitus, or hypo/hyperthyroidism.
• • Carriers of pacemakers, neurostimulators or any other electronic device that is considered to make the interpretation of biometric records difficult.
• • Anatomical problem that makes the use of the device impossible.
• • Patients in whom it is expected that a change in migraine preventive treatment or other usual treatment will be possible during the study period.